Moreover, the deficiency or reduction of Ikaros is deemed as a common step and potential diagnostic precursor of progressive myeloid disease in patients with CML (Beer et al., 2015). This evidence concerns the gene IKZF1 and chronic myelogenous leukemia, BCR-ABL1 positive.